Baby boomers won\'t cop it: Ken Henry\'s aged care warning

Advertisement

Baby boomers won't cop it: Ken Henry's aged care warning

Former Treasury secretary Ken Henry says the aged care system is horribly complex and underfunded and the baby boomers will not tolerate it.

Mr Henry told an aged care inquiry on Wednesday the difficulties older people encountered when trying to navigate the system was an enduring source of discomfort to him since his decade running the Treasury until 2011. He toyed with using the word "unconscionable".

Former Treasury secretary Ken Henry says the aged care system is "horribly complex" for consumers.Credit:Louise Kennerley

"The system overall is horribly complex and it contains a very high level of uncertainty for people," Mr Henry said. These were people who were elderly, vulnerable, probably suffering emotional distress, and possibly mentally impaired.

"Too many have little or inadequate family support, and they confront the aged care system knowing nothing about it, knowing that they have no real option but to throw themselves into the system because it's quite simply impossible for them to look after themselves And they're bewildered," he said.

Advertisement

Successive intergenerational reports identified aged care as the fastest growing component of government expenditure and the fiscal burden was expected to increase as age expectancy increased, treatments advanced and the baby boomer bulge moved into aged care, Mr Henry said. Even a decade ago, he could see the system was unsustainable.

"It's underfunded, it's under-resourced and it will not be tolerated. It seemed to me that the baby boomers, which is a very politically powerful cohort, would not tolerate a continuance of this system," he said.

The Royal Commission into Aged Care Quality and Safety is investigating the funding, financing and prudential regulation of aged care during a five-day hearing in Sydney.

A rise in the number of people requiring aged care is expected to start taking effect from 2030 as the baby boomers enter their 80s. The hearing heard concerns have been increasing over the last decade, not just about the financial sustainability of the system, but whether it was providing an adequate level of care — two themes apparently in tension with one another.

University of NSW economist John Piggott suggested on Tuesday that a hypothecated levy — a dedicated tax for a specific expenditure — could be invested in a new aged care fund managed by the Future Fund system. Any surplus that accrued over the next decade could be used to pay for the demographic bulge.

Mr Henry said he supported the concept of this levy, but it should be run very lean and not calibrated to establish reserves for future expenditure.

It was too late for such a scheme, he said, because it was "intergenerationally unfair" to ask people not only to pay for the costs of their parents and grandparents in aged care, but also pre-fund their own aged care.

"I think it's enough that we ask of them that they, as workers, fund the aged care of their parents and grandparents. I think that's enough for society to expect of them," he said.

The beauty of a levy was that government would need a mandate to increase it, so it would have to constantly explain to the population the connection between the tax and the social benefit, Mr Henry said.

Earlier in the day, former federal treasurer and Future Fund chairman Peter Costello told the hearing the means testing paperwork for aged care was so complicated that even he struggled to fill it in for his family members.

Then treasurer Peter Costello counsels his prime minister John Howard in question time in 2002.Credit:Pat Scala

"I think there are over 100 questions and 27 pages and, you know, I think I'm reasonably financially literate," Mr Costello said. "I had a lot of trouble filling it in. I don't know how a person going into a nursing home would ever be able to fill it in."

Loading

Mr Costello, who is also the chairman of Nine Entertainment Corporation which owns this masthead, had been asked whether there was scope for the primary residence to be used for the purposes of contributing to aged care to a greater extent than it is now.

Apparently alluding to the former prime minister Paul Keating's proposal for a HECS-style loan system, he said people could already use their homes as security on a bond, but this should be done "knowingly and in advance" and there should be products that allowed them to do so in their lifetimes.

"If you come around and try to take their assets after they've died, I think you can expect to run into a lot of opposition there," he said.

Trump Biden 2020

Our weekly newsletter will deliver expert analysis of the race to the White House from our US correspondent Matthew Knott. Sign up for the Herald's newsletter here, The Age's here, Brisbane Times' here and WAtoday's here

Trump Biden 2020

Our weekly newsletter will deliver expert analysis of the race to the White House from our US correspondent Matthew Knott. Sign up for The Sydney Morning Herald's newsletter here, The Age's here, Brisbane Times' here and WAtoday's here

Most Viewed in National

Loading

Baby boomers won\'t cop it: Ken Henry\'s aged care warning

Mouni Roy Gives Expressions During Photoshoot Actress Video Goes Viral - Mouni Roy ने फोटोशूट के दौरान दिये जबरदस्त एक्सप्रेशंस, खूब Viral हो रहा है Video

Mouni Roy ने फोटोशूट के दौरान दिये जबरदस्त एक्सप्रेशंस, खूब Viral हो रहा है Video

मौनी रॉय (Mouni Roy) की कुछ फोटो और वीडियो सोशल मीडिया पर जमकर वायरल हो रही हैं, जिसमें एक्ट्रेस का अंदाज और उनकी अदाएं देखने लायक हैं.

Mouni Roy ने फोटोशूट के दौरान दिये जबरदस्त एक्सप्रेशंस, खूब Viral हो रहा है Video

मौनी रॉय (Mouni Roy) ने फोटोशूट के दौरान दिये जबरदस्त एक्सप्रेशंस

खास बातें

  • मौनी रॉय ने जबरदस्त अंदाज में कराया फोटोशूट
  • एक्ट्रेस ने फोटोशूट के दौरान दिये जबरदस्त एक्सप्रेशंस
  • मौनी रॉय के वीडियो ने खींचा सबका ध्यान
नई दिल्‍ली:

टीवी से बॉलीवुड तक अपने काम से लोगों का दिल जीतने वाली मौनी रॉय (Mouni Roy) इन दिनों सोशल मीडिया पर खूब एक्टिव नजर आ रही हैं. उनकी फोटो हो या वीडियो, खूब वायरल होती हैं. मौनी रॉय अपने स्टाइल को लेकर भी हमेशा चर्चा में बनी रहती हैं. हाल ही में मौनी रॉय की कुछ फोटो और वीडियो सोशल मीडिया पर जमकर वायरल हो रही हैं, जिसमें एक्ट्रेस का अंदाज और उनकी अदाएं देखने लायक हैं. इन तस्वीरों में मौनी रॉय हाथ में बुक लेकर फोटोशूट कराती नजर आ रही हैं. मौनी रॉय ने इन फोटो और वीडियो को अपने इंस्टाग्राम एकाउंट से शेयर किया है, जिसे फैंस भी खूब पसंद कर रहे हैं. 

यह भी पढ़ें

मौनी रॉय (Mouni Roy) अपनी फोटो में व्हाइट स्कर्ट और डार्क ब्लू क्रॉप टॉप में नजर आ रही हैं, जिसमें उनका लुक भी काफी लाजवाब लग रहा है. फोटोशूट के दौरान मौनी रॉय के एक्सप्रेशंस भी कमाल के देती हुई नजर आ रही हैं. इन तस्वीरों और वीडियो को साझा करते हुए उन्होंने लिखा, "एक पुरानी फिल्म देखो, एक अच्छी किताब पढ़ो, आराम करें और दिन का आनंद लें. हैप्पी संडे." मौनी रॉय की इन तस्वीरों पर फैंस के साथ-साथ टीवी कलाकार भी खूब कमेंट कर रहे हैं. खास बात तो यह है कि अब तक इस पोस्ट पर 4 लाख से भी ज्यादा लाइक्स और कमेंट्स आ चुके हैं.

Listen to the latest songs, only on JioSaavn.com

बता दें कि यह पहली बार नहीं है जब मौनी रॉय (Mouni Roy) की फोटो और वीडियो ने इस कदर लोगों का ध्यान खींचा हो. एक्ट्रेस के वर्क फ्रंट की बात करें तो वह जल्द ही अपकमिंग वेबसीरीज लंदन कॉन्फिडेंशियल के जरिए ओटीटी की दुनिया में एंट्री करने वाली हैं. मौनी रॉय स्टारर यह सीरीज क्राइम और थ्रिलर से भरपूर है. एक्ट्रेस के बॉलीवुड करियर की बात करें तो उन्होंने अक्षय कुमार की फिल्म गोल्ड से फिल्मी दुनिया में कदम रखा था. इसके बाद वह आखिरी बार फिल्म मेड इन चाइना में भी नजर आई थीं, जिसमें उन्होंने एक्टर राजकुमार राव के साथ मुख्य भूमिका अदा की थी. 
 

अन्य खबरें
 

Baby boomers won\'t cop it: Ken Henry\'s aged care warning

Sensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cuesSensex, Nifty start on cautious note amid tepid global cues

Sensex, Nifty start on cautious note amid tepid global cues

 
Domestic equity benchmarks Sensex and Nifty opened on a cautious note on Wednesday tracking mixed cues from global markets ahead of the US Federal Reserve's policy outcome.
The 30-share BSE index was trading 53.41 points or 0.14 per cent higher at 39,097.76; while the NSE Nifty rose 14.40 points or 0.12 per cent to 11,536.20.
M&M was the top gainer in the Sensex pack, rising around 3 per cent, followed by Bajaj Auto, Maruti, L&T, Tata Steel, UltraTech Cement and Nestle India.
On the other hand, HCL Tech, Axis Bank, ICICI Bank, Bajaj Finance and SBI were among the laggards.
In the previous session, Sensex ended 287.72 points or 0.74 per cent higher at 39,044.35, while Nifty rose 81.75 points or 0.71 per cent to 11,521.80.
Meanwhile, exchange data showed that foreign institutional investors bought equities worth Rs 1,170.89 crore on a net basis on Tuesday.
Domestic equities opened on a cautious note tracking mixed cues from global markets ahead of the US Federal Reserve's policy outcome, traders said.
The American central bank began its latest meeting on interest-rate policy on Tuesday, and it will announce its decision later in the day.
Bourses in Shanghai and Hong Kong were in the red, while Seoul and Tokyo were trading with gains in mid-day deals.
Stock exchanges on Wall Street ended higher in overnight trade.
Meanwhile, global oil benchmark Brent crude was trading 1.51 per cent higher at USD 41.14 per barrel.

From around the web

FEATURED ARTICLES
TECHNOLOGY
VIDEO

Baby boomers won\'t cop it: Ken Henry\'s aged care warning

Pfizer’s COVID-19 vaccine update | Candidate’s trial report finds no major safety issues
172@29@17@142!~!172@29@0@53!~!|news|business|pfizers-covid-19-vaccine-update-candidates-trial-report-finds-no-major-safety-issues-5845921.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Here is your gateway to a 1-year FREE MC Pro Subscription, by applying for an American Express® card. Apply Now!
you are here: HomeNewsBusiness
Last Updated : Sep 16, 2020 12:04 PM IST | Source: Moneycontrol.com

Pfizer’s COVID-19 vaccine update | Candidate’s trial report finds no major safety issues

Pfizer expects “conclusive data” by October-end and promised to make public all its safety and efficacy data in case of emergency authorisation for vaccine

Representative Image
Representative Image

Pfizer’s internal COVID-19 vaccine trial report has found no major safety issues with the vaccine candidate, taking into account 12,000 individuals who received their second doses.

Pfizer’s chief scientific officer Mikael Dolsten told investors in a virtual meeting that there are “no safety signals reported so far,” Bloomberg reported.

The trail also reached its 30,000 subject mark and is now targeting total enrolment of 44,000, which will include teenagers and people fighting medical conditions such as HIV, Hepatitis B and Hepatitis C. This was also stated by Pfizer CEO Albert Bourla on September 14.

The trial compares effects of two doses of the vaccine candidate jointly developed by Pfizer and BioNTech, to two shots of placebo. Further, the subjects and internal doctors are unaware of who got the vaccine shot – so as to eliminate bias when reviewing effects, the report added.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

related news

A committee of outside experts – with knowledge of which individuals were given vaccine shots, is also reviewing safety data on a weekly basis and are “not notified of any safety concerns to date,” Kathrin Jansen, Pfizer’s head of vaccine research said during the meet.

Follow our LIVE Updates on the coronavirus pandemic here

Worrisome adverse events haven’t appeared so far, but fatigue has been the most common side effect noticed during the trials so far, as per the company presentation.

The company expects “conclusive data” by October-end and promised to make public all its safety and efficacy data in case of emergency authorisation for the vaccine.

Bourla told the media that the company releasing data is “very unusual” but called it a “must” due to ongoing discussions with the US government and regulators. He had on September 14 said the Americans could get the vaccine by 2020-end if approvals come in.

Pfizer and BioNTech are expected to approach the US Food and Drugs Administration (FDA) for emergency authorisation use, but Bourla said “timing remains unclear.”

On distribution, Pfizer said in case it receives emergency authorisation, the company “has sufficient freezers and thermal shippers to transport the doses, which usually require ultra-low temperatures for long-term storage.”

Pfizer is however also working on developing a version that would allow storage at higher temperatures for longer periods and exploring a new formulation for single dosage, the report added.

Follow our full COVID-19 coverage here
First Published on Sep 16, 2020 12:04 pm
Sections